Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Polycystic Ovary Syndrome × licogliflozin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 1 Overweight 1 Obesity 1 Insulin Resistance 1 Hyperandrogenism 1

Interventions

Inositol 6 follitropin alfa 4 Glycoprotein Hormones, alpha Subunit 3 follitropin beta 2 Metformin 2 Letrozole 2 DLBS3233 2 Clomiphene 2 Chorionic Gonadotropin 2 licogliflozin 1 elagolix 1 cetrorelix 1 Urofollitropin 1 Secretome 1 Progesterone 1 Oils 1 Menotropins 1 Leuprolide 1 Lactalbumin 1 LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1 Itraconazole 1 Folic Acid 1 Diosgenin 1 Cholecalciferol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03152591 2021-01-05

PCOS

Novartis

Phase 2 Completed

29 enrolled 24 charts

Insulin Resistance, Obesity, Polycystic Ovary Syndrome, Hyperandrogenism, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon ⚡